Sinovac Biotech Ltd.
Sinovac Biotech Ltd., a prominent player in the biopharmaceutical industry, is headquartered in Beijing, China. Founded in 2001, the company has established itself as a leader in the development, manufacture, and commercialisation of vaccines, particularly in the fields of infectious diseases. Sinovac's core products include its inactivated vaccines for hepatitis A, hepatitis B, and influenza, which are distinguished by their rigorous safety and efficacy standards. With a strong presence in Asia and expanding operations globally, Sinovac has achieved significant milestones, including the development of its COVID-19 vaccine, CoronaVac, which has been pivotal in various vaccination campaigns worldwide. The company’s commitment to innovation and public health has solidified its market position, making it a trusted name in vaccine production and distribution.
DitchCarbon Score
How does Sinovac Biotech Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sinovac Biotech Ltd.'s score of 15 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sinovac Biotech Ltd.'s reported carbon emissions
Sinovac Biotech Ltd., headquartered in China (CN), currently does not have available carbon emissions data. As a result, specific figures regarding their carbon footprint in kg CO2e are not provided. However, the company is actively engaged in climate commitments and initiatives aimed at reducing its environmental impact. While there are no documented reduction targets or achievements specific to Sinovac Biotech Ltd., it is important to note that the broader industry context often includes commitments to sustainability and emissions reduction. Companies in the biotechnology sector are increasingly focusing on aligning with global climate goals, which may involve setting science-based targets and striving for net-zero emissions in the future. In summary, while specific emissions data for Sinovac Biotech Ltd. is unavailable, the company is likely to be part of the growing trend within the biotechnology industry to enhance climate commitments and reduce carbon emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sinovac Biotech Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
